ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

In Brief: Breast Cancer Coalition Delivers 175,000 Letters To Congress; IL Cancer Council Has New Name

October 11, 1991

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

Moffitt, Ohio State Form Network, Invite Major Cancer Centers to Join

May 30, 2014

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012